Segall Bryant & Hamill, LLC Novo Nordisk A S Transaction History

Segall Bryant & Hamill, LLC

$7.07 Billion
Q4 2024

A detailed history of Segall Bryant & Hamill, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 99,183 shares of NVO stock, worth $8.74 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

99,183

Previous 318,540 68.86%

Holding current value

$8.74 Million

Previous $37.9 Million 77.51%

% of portfolio

0.12%

Previous 0.53%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$85.0 - $120.04 $18.6 Million - $26.3 Million	-219,357 Reduced 68.86%	99,183 $8.53 Million
Q3 2024 Nov 08, 2024	BUY	$119.07 - $145.42 $11.2 Million - $13.7 Million	93,922 Added 41.81%	318,540 $37.9 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $2.79 Million - $3.34 Million	-22,735 Reduced 9.19%	224,618 $32.1 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $241,592 - $321,586	-2,366 Reduced 0.95%	247,353 $31.8 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $32 Million - $38.4 Million	-364,070 Reduced 59.32%	249,719 $25.8 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $25.7 Million - $56.3 Million	282,265 Added 85.14%	613,789 $55.8 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $808,600 - $895,017	5,184 Added 1.59%	331,524 $53.7 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $3.28 Million - $3.94 Million	24,784 Added 8.22%	326,340 $51.9 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $4.37 Million - $5.77 Million	42,660 Added 16.48%	301,556 $40.8 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $24.4 Million - $29.9 Million	256,071 Added 9064.46%	258,896 $25.7 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $263,007 - $317,925	2,825 New	2,825 $313,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $278,531 - $340,117	-2,905 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$84.42 - $106.62 $23,637 - $29,853	280 Added 10.67%	2,905 $278,000
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $177,607 - $222,495	2,625 New	2,625 $219,000

Others Institutions Holding NVO

# of Institutions

1,881

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account

Segall Bryant & Hamill, LLC Novo Nordisk A S Transaction History